BRIEF-Invivyd Announces Positive Full Phase 1/2 Clinical Data For Vyd2311

Reuters
06/26
BRIEF-Invivyd Announces Positive Full Phase 1/2 Clinical Data For Vyd2311

June 26 (Reuters) - Invivyd Inc IVVD.O:

  • INVIVYD ANNOUNCES POSITIVE FULL PHASE 1/2 CLINICAL DATA FOR VYD2311, A NEXT GENERATION COVID-19 MONOCLONAL ANTIBODY FOR POTENTIAL USE AS A NON-VACCINE PREVENTATIVE AND FOR TREATMENT OF ACTIVE INFECTION

  • INVIVYD INC - VYD2311 SHOWS ATTRACTIVE SAFETY PROFILE ACROSS ALL DOSING COHORTS

  • INVIVYD INC - TYPE C MEETING WITH FDA SCHEDULED FOR EARLY Q3

Source text: ID:nGNX8R7BBD

Further company coverage: IVVD.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10